CAS: 131-49-7; Meglumine Amidotrizoate

该化合物是一种碘化对比介质,主要用于放射成像程序,包括血管成像,脉冲和计算断层成像(CT) . 它的高碘含量确保了极好的放射线,使血管和尿道结构能够清晰可见. 化合物的水溶性和低粘度有助于顺利管理,而其有利的安全特征则最大限度地减少不良反应. Meglune Diatrizoate 因其通过肾脏路径快速排泄,减少了系统留存,而特别受到重视. 它在生理条件下的稳定确保了诊断应用的可靠性能. 该剂由于在提高成像对比和诊断准确性方面的效力,在临床环境中被广泛使用.

结构式图片

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-6096874-A
    优先权日:1990-10-01
    标 题:High affinity tamoxifen derivatives
    发明人:WALLACE SIDNEY; YANG DAVID; DELPASSAND EBRAHIM; CHERIF ABDALLAH; QUADRI SYED M
    权利人:UNIV TEXAS
    摘要:The synthesis of tamoxifen derivatives, most particularly halo, halo alkyl, hydroxy, and amino tamoxifen derivatives is disclosed. The native tamoxifen molecule includes a substituted chemical group positioned on the aliphatic chain of the tamoxifen molecule. Particular tamoxifen derivatives of the invention include chloro, bromo, iodo, fluoro, amino and DTPA tamoxifen derivatives, and corresponding lower alkyl halogenated forms. The halogenated tamoxifen derivatives possess superior binding affinities for estrogen receptor rich tissues, such as uterine tissue and breast tissue, relative to unsubstituted native tamoxifen. Radiolabeled forms of the tamoxifen derivatives may be used as highly specific imaging agents for estrogen receptor rich tissues. The fluoro and bromo tamoxifen derivatives are particularly useful for imaging estrogen receptors by PET whereas the iodinated tamoxifens are particularly useful in imaging estrogen receptors by SPECT. Rapid and efficient methods of preparing the tamoxifen derivatives having high specific activity (>6 Ci/μmol) are also disclosed. Aliphatic chain substituted tamoxifen derivatives are shown to possess greater estrogen receptor binding affinity and more potent tumor cell inhibition than tamoxifen or tamoxifen derivatives substituted at other locations on the molecule (i.e., non-aliphatic chain substituted tamoxifen). The tanioxifen derivatives of the present invention may advantageously be used as anti-cancer therapeutic agents to halt estrogen-receptor positive tumors, such as those of breast and uterine tissue. The present invention also provides a hydrophilic DTPA-tamnoxifen analogue, and uses thereof in imaging estrogen receptor positive ER+ lesions.

    专利号:US-2011104052-A1
    优先权日:2007-12-03
    标 题 :Methods of synthesis and use of chemospheres
    发明人:BARNETT BRADLEY POWERS; GESCHWIND JEFFREY
    权利人:UNIV JOHNS HOPKINS
    摘要:The present invention provides, in general, compositions comprising a hydrogel and an agent, for example a therapeutic agent or an imaging agent, for locoregional delivery. In certain preferred embodiments of the invention, the hydrogel compositions are detectable by Magnetic Responance and CT Scan and are used for locoregional delivery of therapeutic agents, for example chemotherapeutic agents. The invention also features polymer matrix compositions comprising nanoparticles that can be loaded after polymerization with bioactive agents, for example a diagnostic agent or therapeutic agent.

    专利号:US-9186422-B2
    优先权日:2003-08-11
    标题 :Radio-opaque compounds, compositions containing same and methods of their synthesis and use
    发明人:PATHAK CHANDRASHEKHAR P; THIGLE SANJAY M
    权利人:PATHAK CHANDRASHEKHAR P; THIGLE SANJAY M; PATHAK HOLDINGS LLC
    摘要:Radio-opaque biodegradable compositions are formed by modifying terminal groups of synthetic and natural biodegradable polymers such as polylactones with iodinated moieties. The biodegradable property of the compositions renders them suitable for use in medical field such as drug delivery, imaging. Compounds disclosed in this invention exist as neat liquid. Certain compositions disclosed in this invention form hydrophobic iodine rich domains when dissolved in water, such domains provide better contrasting properties as well as ability to dissolve hydrophobic bioactive drugs. Certain iodinated moieties disclosed in the invention are capable of cross linking natural proteins in situ in presence of suitable catalysts and co-catalysts.

    专利号:US-12343191-B2
    优先权日:2019-12-02
    标题 :Medical image synthesis for motion correction using generative adversarial networks
    发明人:CRABB BRENDAN THOMAS; NOO FREDERIC NICOLAS FIRMIN; FINE GABRIEL CHAIM
    权利人:UNIV UTAH RES FOUND
    摘要:A computer system is configured to remove motion artifacts in medical images using a generative adversarial network (GAN). The computer system instantiates the GAN having one or more generative network(s) and one or more discriminative network(s) that are pitted against each other to train a generative model and a discriminative model. The training uses a training dataset including a plurality of medical images that are previously classified as without significant motion artifacts for diagnostic purposes. The discriminative model is trained to classify medical images as real or artificial. The generative model is trained to enhance the quality of a medical image and remove motion artifacts by producing a medical image directly from a post-contrast image, without using a pre-contrast mask.

    专利号:US-7790141-B2
    优先权日:2003-08-11
    标题 :Radio-opaque compounds, compositions containing same and methods of their synthesis and use

    专利号:US-2010290995-A1
    优先权日:2003-08-11
    标 题:Radio-opaque compounds, compositions containing same and methods of their synthesis and use

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Peterson CM, Lin M, Pilgram T, Heiken JP. Prospective randomized trial of iohexol 350 versus meglumine sodium diatrizoate as an oral contrast agent for abdominopelvic computed tomography. J Comput Assist Tomogr. 2011 Mar-Apr;35(2):202-5. doi: 10.1097/RCT.0b013e3182058e76. doi: 10.1590/S0001-37652013000200018.

    合成参考文献


    参考文献:10.1001/archsurg.2009.274
    摘要:Edelman DA, Laker S, Weiner M, Webber JD. Routine postoperative gastrografin studies are not necessary after laparoscopic gastric banding. Arch Surg. 2010 Feb;145(2):211–2; author reply 212. doi: 10.1001/archsurg.2009.274.
    参考文献:10.1007/s11894-011-0217-5
    摘要:Boone D, Halligan S, Taylor SA. Evidence review and status update on computed tomography colonography. Curr Gastroenterol Rep. 2011 Oct;13(5):486–94. doi: 10.1007/s11894-011-0217-5.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知